<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01109225</url>
  </required_header>
  <id_info>
    <org_study_id>2009-A00537-50</org_study_id>
    <nct_id>NCT01109225</nct_id>
  </id_info>
  <brief_title>Relation Between Aldosterone and Cardiac Remodeling After Myocardial Infarction</brief_title>
  <acronym>REMI</acronym>
  <official_title>Multiparametric Study of Cardiac Remodeling After Myocardial Infarction Revascularized in Acute Phase : Relation With the Serum Concentrations in Aldosterone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to determine whether aldosterone blood levels are predictive of cardiac
      remodeling at 6 months following myocardial infarction with ST elevation (STEMI),
      independently of conventional predictive factors (size of myocardial infarction, age,
      hypertension, etc.) in revascularized patients during the acute phase of MI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After myocardial infarction, the evolution toward cardiac failure is generally linked to a
      progressive worsening of cardiac dysfunction and remodeling. Cardiac remodeling is largely
      the consequence of myocardial injury due to myocardial infarction, although other parameters
      including age, arterial hypertension, etc. may also represent important predictors.
      Aldosterone blood levels measured within the first hours of admission for myocardial
      infarction is associated with increased rates of adverse outcomes. Aldosterone acts on wound
      healing and fibrosis processes in the myocardium as well as on systemic volemia.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 2010</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac remodeling within 6 months of myocardial infarction as defined as the change in left ventricle volumes (increase of more than 20 % of the diastolic volume of the left ventricle)</measure>
    <time_frame>from initial assessment to 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vascular and cardiac parameters measured during the initial assesment and at 6 months (both functional and structural - by echocardiography or MRI)</measure>
    <time_frame>from initial assessment to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long-term cardiac remodeling measured by echocardiography at 3 to 7 years of initial enrollment</measure>
    <time_frame>at 3 to 7 years of initial enrollment</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">145</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Myocardial infarction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients. Patients hospitalized for a first myocardial infarction with known shift of the segment ST revascularized in acute phase by primary angioplasty and dated less than 4 days.
Intervention:
blood sample
MRI
echocardiography
urine sample
pulmonary echography
vascular check
renal echography</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>blood sample</intervention_name>
    <arm_group_label>Myocardial infarction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MRI</intervention_name>
    <arm_group_label>Myocardial infarction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>echocardiography</intervention_name>
    <arm_group_label>Myocardial infarction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>urine sample</intervention_name>
    <arm_group_label>Myocardial infarction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pulmonary echography</intervention_name>
    <arm_group_label>Myocardial infarction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>vascular check</intervention_name>
    <arm_group_label>Myocardial infarction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>renal echography</intervention_name>
    <arm_group_label>Myocardial infarction</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Man or woman hospitalized for a first myocardial infarction with known shift of the
             segment ST revascularized in acute phase by primary angioplasty and dated less than 4
             days

          -  Patient presenting a stable clinical state

          -  Patient presenting a regular sinusal cardiac rhythm

          -  Patient having an age ≥ 18 years

        Exclusion Criteria:

          -  Counter-indication with examination MRI

          -  Severe claustrophobia

          -  Antecedent of over-sensitiveness to gadolinium salts

          -  Nonischaemic Cardiopathy

          -  Cardiac surgery planed in the 6 months

          -  Women into old to procreate without effective contraception
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolas GIRERD, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre d'Investigation Clinique Plurithématique 1433/INSERM/CHRU de Nancy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nancy Brabois university hospital</name>
      <address>
        <city>Vandoeuvre les Nancy</city>
        <state>Meurthe et Moselle</state>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 22, 2010</study_first_submitted>
  <study_first_submitted_qc>April 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 23, 2010</study_first_posted>
  <last_update_submitted>May 12, 2017</last_update_submitted>
  <last_update_submitted_qc>May 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>aldosterone</keyword>
  <keyword>myocardial infarction</keyword>
  <keyword>cardiac remodeling</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

